NFKB1 and cholangiocarcinoma: In cholangiocarcinoma cells [44], DIM has been shown to inhibit Akt phosphorylation and NF-κB, and, recently, DIM has been shown to be protective against tumor progression in skin through inhibition of NF-κB signaling pathway [87].